|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.66 USD | +0.97% |
|
-8.23% | +0.22% |
| Capitalization | 736.22Cr 632.63Cr 589.94Cr 548.19Cr 1.02TCr 66TCr 1.1TCr 6.78TCr 2.66TCr 32TCr 2.76TCr 2.7TCr 1,17200Cr | P/E ratio 2025 * |
67.5x | P/E ratio 2026 * | 51.4x |
|---|---|---|---|---|---|
| Enterprise value | 728.13Cr 625.68Cr 583.47Cr 542.17Cr 1.01TCr 66TCr 1.09TCr 6.71TCr 2.64TCr 31TCr 2.73TCr 2.67TCr 1,15900Cr | EV / Sales 2025 * |
3.1x | EV / Sales 2026 * | 2.49x |
| Free-Float |
84.41% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Hims & Hers Health, Inc.
| 1 day | +0.93% | ||
| 1 week | -8.23% | ||
| Current month | +0.22% | ||
| 1 month | -10.23% | ||
| 3 months | -40.54% | ||
| 6 months | -37.46% | ||
| Current year | +0.22% |
| 1 week | 29.92 |  | 36.45 |
| 1 month | 29.92 | | 38.03 |
| Current year | 29.92 | | 36.45 |
| 1 year | 23.97 | | 72.98 |
| 3 years | 5.65 | | 72.98 |
| 5 years | 2.72 | | 72.98 |
| 10 years | 2.72 | | 72.98 |
| Manager | Title | Age | Since |
|---|---|---|---|
Andrew Dudum
CEO | Chief Executive Officer | 37 | 20/01/2021 |
Oluyemi Okupe
DFI | Director of Finance/CFO | 40 | 24/01/2022 |
Mo Elshenawy
CTO | Chief Tech/Sci/R&D Officer | 52 | 08/05/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Andrew Dudum
CHM | Chairman | 37 | 20/01/2021 |
Delos Cosgrove
BRD | Director/Board Member | 85 | 20/01/2021 |
David Wells
BRD | Director/Board Member | 54 | 20/01/2021 |
| Name | Varia. Jan 1. | Weight | AuM | |
|---|---|---|---|---|
 | +5.15% | 0.02% | 324 M€ |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.97% | -8.23% | +25.64% | +332.14% | 736.22Cr | |
| -2.55% | -11.56% | -27.06% | -73.72% | 128.67Cr | |
| -0.99% | -0.44% | - | - | 93Cr | |
| -1.38% | +0.89% | +36.85% | +427.19% | 66Cr | |
| -10.69% | -11.23% | -25.46% | +988.24% | 66Cr | |
| -4.84% | -11.26% | -44.87% | -93.97% | 8.12Cr | |
| -3.57% | -8.47% | -60.29% | -92.29% | 5.21Cr | |
| Average | -3.30% | -0.01% | -15.87% | +247.93% | 157.64Cr | |
| Weighted average by Cap. | -0.53% | -3.46% | +15.32% | +323.83% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 234.66Cr 201.64Cr 188.04Cr 174.73Cr 326.02Cr 21TCr 351.55Cr 2.16TCr 849.4Cr 10TCr 880.03Cr 861.98Cr 37TCr | 276.45Cr 237.55Cr 221.52Cr 205.84Cr 384.07Cr 25TCr 414.15Cr 2.55TCr 1TCr 12TCr 1.04TCr 1.02TCr 44TCr |
| Net income | 12Cr 10Cr 9.6Cr 8.92Cr 17Cr 1.08TCr 18Cr 110.41Cr 43Cr 517.26Cr 45Cr 44Cr 1.91TCr | 15Cr 13Cr 12Cr 11Cr 20Cr 1.33TCr 22Cr 135.36Cr 53Cr 634.14Cr 55Cr 54Cr 2.34TCr |
| Net Debt | -8.08Cr -6.95Cr -6.48Cr -6.02Cr -11Cr -730.14Cr -12Cr -74Cr -29Cr -348.91Cr -30Cr -30Cr -1.29TCr | -49Cr -42Cr -39Cr -37Cr -68Cr -4.43TCr -74Cr -452.15Cr -177.66Cr -2.12TCr -184.06Cr -180.29Cr -7.81TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/26/13 | 32.53 $ | +0.60% | 1,00,96,969 |
| 12/26/12 | 32.34 $ | +2.05% | 2,56,33,790 |
| 09/26/09 | 31.69 $ | -6.44% | 2,53,99,622 |
| 08/26/08 | 33.87 $ | -4.48% | 1,56,11,065 |
| 07/26/07 | 35.46 $ | 0.00% | 1,09,86,356 |
Delayed Quote Nyse, January 13, 2026 at 11:52 pm IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- HIMS Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition